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Giant congenital melanocytic nevi are rare, with an estimated incidence of approx-
imately 1 in 20,000 live births. They increase the lifetime risk for malignant 
melanoma and neurological deficits, including leptomeningeal melanocytosis and 
epilepsy. Recently, we encountered two patients in whom giant congenital melano-
cytic nevi were noted at birth. Case 1 presented with the largest nevus spreading 
across the posterior scalp, neck, chest wall, shoulder and upper back. At the age of 
2 months, magnetic resonance imaging (MRI) was performed and no leptomenin-
geal melanocytosis was found. Case 2 presented with a huge nevus covering most 
parts of the lower abdomen, lower back, buttocks and bilateral upper thighs. She 
also had normal MRI findings in the newborn period. At the age of 7 years, leptome-
ningeal thickening on the surface of the junction between the pons and midbrain 
was found on brain MRI although she was neurologically asymptomatic. Here, we 
describe these two cases with congenital melanocytic nevi and review the litera-
ture about its clinical manifestations, outcomes, risks for malignant melanoma and 
neurocutaneous melanosis, and possible surgical interventions.
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1.  Introduction
Congenital melanocytic nevi (CMN) are pigmented 
lesions presenting on the skin of about 1% of all 
newborns at or shortly after birth.1 They result from 
an aberration of the normal development of the 
neural crest from which melanocytes and neuroid 
cells are derived. Kopf et al2 suggested classifying 
the lesions by surface diameter: small lesions 
 < 1.5 cm, intermediate lesions ≤ 1.5−20.0 cm and 
giant lesions, ≥ 20.0 cm. The majority of lesions are 
small and solitary, with low potential of becoming 
malignant. Giant melanocytic nevi, with multifocal 
involvement, are less frequent than small nevi but 
show significantly greater risk of developing malig-
nant melanomas and neurocutaneous melanocytosis 
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(NCM),3−5 particularly those in a posterior axial loca-
tion and when they are associated with satellite 
melanocytic nevi.6 We report two cases in whom 
giant CMN were noted at birth. One case devel-
oped neurocutaneous melanosis with leptomenin-
geal melanocytosis on the surface of the junction 
between the upper pons and the midbrain at 
7 years of age. The other case was only 2 months 
old and being followed-up at our clinic. Early evalu-
ation and surgical intervention are recommended 
to prevent malignant transformation, and avoid 
cosmetic and future psychological ramifications.
2.  Case Report
2.1.  Case 1
A 3306-g male baby was born via the vaginal route 
to a 34-year-old gravida 1, para 1 mother at the 
gestational age of 40 weeks. At birth, a huge hy-
perpigmented flat to papular skin lesion with a dia-
meter of more than 20 cm was noted and covered 
the posterior scalp, neck, chest wall, shoulder and 
upper back (Figure 1). It contained irregularly shaped 
macules, papules, patches, plaques and nodules 
with variegated colors, including reddish, grayish, 
blackish and light-to-dark brownish. Other smaller 
pigmented nevi were scattered across the face, 
bilateral lower legs, feet and planta, and mea-
sured from 1 cm to 5 cm in diameter. He was referred 
to our pediatric department for dermatological and 
neuro logical assessment. No signs of neurological 
abnormalities were found after 2 months of age, 
and his growth and development have been nor-
mal. Magnetic resonance imaging (MRI) of the brain 
and spine was negative for melanosis or thickening 
of the leptomeninges.
2.2.  Case 2
A 3000-g female baby was born via cesarean section 
to a 34-year-old gravida 2, para 2 mother at the 
gestational age of 39 weeks. At birth, a huge hy-
perpigmented skin lesion of more than 30 cm in di-
ameter was found over her lower abdomen, lower 
back, buttocks and bilateral thighs (Figure 2). The 
lesion contained irregularly shaped macules, pap-
ules and plaques with various colors. A number of 
smaller pigmented nevi were scattered over the 
scalp, face, fingers, lower legs and toes. A skin 
biopsy was taken from the right thigh at 2 months 
of age and showed hyperpigmentation of the basal 
layer of the epidermis. The dermis contained nevus 
cells in nests and sheets throughout the dermis, 
within the hair follicles, sweat ducts and vessel 
walls. No cellular atypia was noted. At the same 
time, MRI of the brain revealed mild frontal corti-
cal atrophy without leptomeningeal melanocyto-
sis. At the age of 7 years, new blackish to dark 
brownish hyperpigmented nevi with rough, nodu-
lar, verrucous surfaces, hypertrichosis and many 
satellite lesions were found over the face, lower 
abdomen, lower back, buttocks and the four ex-
tremities. No neurological abnormality was noted 
during physical examination. On MRI, leptomenin-
geal melanocytosis with a linear high-signal com-
ponent on the surface of the junction between the 
upper pons and midbrain was found (Figure 3).
3.  Discussion
CMN are benign pigmented skin disorders found in 
about 1−2% of all newborns.1 In the neonatal pe-
riod, the lesions may be dark or light, with a poorly 
or well-defined margin, flat or papular, and may 
Figure 1 Case 1 giant congenital melanocytic nevi on 
the posterior scalp, neck, shoulder and upper back with 
maculopapular to nodular lesions noted at birth. The 
color and size are greatly variable.
Figure 2 Case 2 giant congenital melanocytic nevi on 
the lower abdomen, lower back, buttocks and bilateral 
thighs noted at birth. Satellite lesions are seen.
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show hair growth. Satellite lesions are often ob-
served. As the child grows, some nevi show marked 
hyperpigmentation, irregular margins and surface 
changes including papules, nodules and verrucous 
plaques. The most common locations of CMN are 
the trunk and thighs. Although the majority of le-
sions are small, they may be exceedingly large. 
Giant CMN are 200 times less frequent than small 
ones and occur in approximately 1 in 20,000 live 
births in Caucasian populations.7
It is thought that, between the 5th and 24th weeks 
of gestation, a morphogenic error in the neuroec-
toderm results in dysregulated growth of melano-
blasts to cause CMN.8 Perturbations in migration, 
proliferation or differentiation of the neural crest-
derived melanoblasts may be linked to the c-met 
proto-oncogene, which controls the expression of 
the tyrosine kinase receptor Met.9
All CMN may be regarded as potential malignant 
melanoma precursors and should be followed up 
for neurological complications, regardless of their 
size, although the increased risk associated with 
small lesions is controversial.10 The reported life-
time risk for developing melanoma is between 0% 
and 4.9% in patients with CMN < 20 cm in diameter, 
and between 4.5% and 10% in patients with giant 
CMN.11,12 Patients in whom such nevi are located on 
the head, posterior neck and paravertebral area, 
or when they are associated with satellite nevi, 
seem to be at higher risk of developing NCM than 
patients with giant CMN limited to the extremities, 
or those who lack satellite nevi.8 Repeated MRI at 
yearly intervals appears to be a useful tool for the 
early detection of melanin deposition, particularly 
in the temporal lobes, cerebellum, pons and/or 
medulla, in neurologically asymptomatic patients 
with giant CMN.5 Symptoms and signs such as 
increased intracranial pressure, hydrocephalus, 
seizure and developmental delay are often found 
in symptomatic NCM before 2 years of age, and 
the prognosis is often poor; approximately 70% of 
patients die before the age of 10 years.
The histopathological features of patients with 
small and medium-sized CMN are superficial and 
patchy involvement of nevus cells, whereas giant 
CMN show diffuse pandermal, subcutaneous in-
volvement, with nodular proliferations of high cel-
lularity or nuclear atypia.13 Immunohistochemical 
studies showed the expression of S-100 protein, 
HMB45 and melan-A in CMN and proliferative nod-
ules. Analysis of cell cycle and proliferative markers 
Mib-1, p16, p21, p27 and c-myc revealed many 
similarities and a few differences between CMN 
and proliferative nodules. Most CMN lack p16 muta-
tions and show lower p21 and p53 expression com-
pared with malignant melanoma.14 These markers 
may aid early detection of malignant changes in 
CMN. Using comparative genomic hybridization, we 
can also identify and differentiate structural chromo-
somal aberrations commonly found in melanoma.15
The management of CMN needs to be tailored 
for each patient. All locations of the nevi, size of 
the nevi, cosmetic issues regarding the nevi or re-
sultant surgical scars, risk of surgery, psychological 
implications, risk of melanoma and risk of NCM need 
to be taken into account in the decision-making 
process. For CMN of < 1.5 cm in diameter, the risk 
of developing a melanoma is considered to 
be low enough that prophylactic removal of these 
lesions might not be warranted; but any suspicious 
changes, onset of symptoms or an irregular pattern 
of small CMN require an excisional biopsy. Lesions of 
the scalp might spontaneously become involuted.16
For giant or clinically atypical CMN, early eval-
uation and surgical removal may decrease the risk 
for developing melanoma. One study has suggested 
that treatment is best accomplished in the first 
weeks of life because nevus cells migrate into the 
deeper dermis and subcutaneous fat tissue soon 
after birth.17 Curettage, dermabrasion, cryother-
apy with liquid nitrogen in combination with laser 
therapy, the use of tissue expanders and skin grafts 
or local flaps have been reported for the manage-
ment of large congenital melanocytic nevi.18−21 In 
one study where 295 patients with pigmented nevi 
underwent surgical treatment,22 it was concluded 
that small and medium-size nevi (≤ 5 cm in diame-
ter) can be removed in a one-stage procedure with 
suturing of the wound and local plasty or a free-
tissue skin graft. Large nevi (> 5 cm in diameter) 
mandate a staged excision or one-stage removal 
with prior use of a tissue expander or pre-suturing. 
Giant nevi require staged treatment with the use 
Figure 3 T1-weighted brain magnetic resonance imag-
ing showed the presence of a linear high-signal compo-
nent (arrows) on the surface of the junction between 
the upper pons and the midbrain, compatible with the 
appearance of leptomeningeal melanocytosis.
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of an intermediate-thickness skin graft or removal 
of the superficial layers of the nevus.
The objective of surgical treatment is to im-
prove the cosmetic appearance of CMN and reduce 
the risk for malignancy, but it does not adequately 
address the risk of developing melanomas from nevus 
remnants located in the dermis. Furthermore, care-
ful long-term follow-up is essential to monitor the 
cosmetic outcomes and the risk of malignancy.
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